Get started
CAESARS ENTCAESARS ENTCAESARS ENT

CAESARS ENT

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Bonds

1CZR chart


Full chart

1CZR upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.19 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.015 EUR
Net income (FY)
‪−268.54 M‬ EUR
Revenue (FY)
‪10.86 B‬ EUR
Shares float
‪194.97 M‬
Beta (1Y)
1.58

Employees


Employees (FY)
‪50 K‬
Change (1Y)
‪−1 K‬ −1.96%
Revenue / Employee (1Y)
‪217.25 K‬ EUR
Net income / Employee (1Y)
‪−5.37 K‬ EUR

About Caesars Entertainment, Inc.


Sector
Consumer Services
Industry
Casinos/Gaming
CEO
Thomas R. Reeg
Website
caesars.com
Headquarters
Reno
Founded
1937
FIGI
BBG01TNY0ZW2
Caesars Entertainment, Inc. engages in the management of casinos and resorts under the Caesars, Harrah's, Horseshoe, and Eldorado brands. It operates through the following segments: Las Vegas, Regional, Caesars Digital, Managed and Branded, and Corporate and Other. The company was founded in 1937 and is headquartered in Reno, NV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1CZR news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1CZR highest yielding bonds


USU1230PAD3
CAESARS ENT. 24/32 REGS
Yield to maturity
7.09%
Maturity date
Oct 15, 2032
CZR5257446
Caesars Entertainment, Inc. 4.625% 15-OCT-2029
Yield to maturity
6.81%
Maturity date
Oct 15, 2029
CZR5530616
Caesars Entertainment, Inc. 7.0% 15-FEB-2030
Yield to maturity
6.16%
Maturity date
Feb 15, 2030
CZR5740551
Caesars Entertainment, Inc. 6.5% 15-FEB-2032
Yield to maturity
6.10%
Maturity date
Feb 15, 2032
ERI5909471
Caesars Entertainment, Inc. 6.0% 15-OCT-2032
Yield to maturity
—
Maturity date
Oct 15, 2032

See all 1CZR bonds 

Sparks


Curated watchlists where 1CZR is featured.

See all sparks 


Check out other big names from the same industry as 1CZR.

Frequently Asked Questions


The current price of 1CZR is 24.630 EUR — it has increased by 0.12% in the past 24 hours. Watch CAESARS ENT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange CAESARS ENT stocks are traded under the ticker 1CZR.
1CZR stock has risen by 0.51% compared to the previous week, the month change is a 4.17% rise, over the last year CAESARS ENT has showed a 4.17% increase.
We've gathered analysts' opinions on CAESARS ENT future price: according to them, 1CZR price has a max estimate of 52.10 EUR and a min estimate of 24.72 EUR. Watch 1CZR chart and read a more detailed CAESARS ENT stock forecast: see what analysts think of CAESARS ENT and suggest that you do with its stocks.
1CZR reached its all-time high on May 5, 2025 with the price of 24.890 EUR, and its all-time low was 23.645 EUR and was reached on Apr 25, 2025. View more price dynamics on 1CZR chart.
See other stocks reaching their highest and lowest prices.
1CZR stock is 0.12% volatile and has beta coefficient of 1.58. Track CAESARS ENT stock price on the chart and check out the list of the most volatile stocks — is CAESARS ENT there?
Today CAESARS ENT has the market capitalization of ‪5.19 B‬, it has increased by 3.73% over the last week.
Yes, you can track CAESARS ENT financials in yearly and quarterly reports right on TradingView.
CAESARS ENT is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1CZR earnings for the last quarter are −0.39 EUR per share, whereas the estimation was −0.19 EUR resulting in a −108.13% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about CAESARS ENT earnings.
CAESARS ENT revenue for the last quarter amounts to ‪2.58 B‬ EUR, despite the estimated figure of ‪2.58 B‬ EUR. In the next quarter, revenue is expected to reach ‪2.55 B‬ EUR.
1CZR net income for the last quarter is ‪−106.30 M‬ EUR, while the quarter before that showed ‪10.63 M‬ EUR of net income which accounts for ‪−1.10 K‬% change. Track more CAESARS ENT financial stats to get the full picture.
No, 1CZR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 11, 2025, the company has ‪50 K‬ employees. See our rating of the largest employees — is CAESARS ENT on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CAESARS ENT EBITDA is ‪3.35 B‬ EUR, and current EBITDA margin is 32.01%. See more stats in CAESARS ENT financial statements.
Like other stocks, 1CZR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAESARS ENT stock right from TradingView charts — choose your broker and connect to your account.